Clinical trial
Nalmefene Smoking Cessation Study
NCT00202696 · Somaxon Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00202696 |
|---|---|
| Title | Nalmefene Smoking Cessation Study |
| Official title | A Single Center Evaluation of Nalmefene HCl Versus Placebo on Smoking Cessation |
| Lead sponsor | Somaxon Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Smoking Cessation |
| Intervention type | Drug, Other |
| Interventions | nalmefene, Placebo |
| Enrollment | 76 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | May 19, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: